Delivery Order SPE2DB22D1106-SPE2DB25FEZD8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,377.08 to AmerisourceBergen Drug Corp for JEVTANA 60 mg/1.5 mL kits on September 18, 2025, with an ultimate completion date of October 9, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. JEVTANA (cabazitaxel) is a chemotherapy medication used in cancer treatment, reflecting the pharmaceutical supply...
- The Defense Logistics Agency awarded a $16,377.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Jevtana (cabazitaxel) 60 mg/1.5 ml kits. This is a non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of JEVTANA 60 mg/1.5 ml kits, valued at approximately $49.1k with a firm fixed price structure. This non-set-aside, competitively awarded delivery order is scheduled for completion by June 3, 2025, with performance to be executed at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. JEVTANA is a prescription oncology medication used in the treatment of...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a federal contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of a wide range of medical products and pharmaceuticals. This $7,368.99 firm fixed-price delivery order, awarded on April 23, 2024, is for the supply of the chemotherapy drug JEVTANA 60 MG/1.5 ML KIT 1.5ML. The contract has an ultimate completion date of May 14, 2024 and does not have a set-aside...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, with a ceiling value of $7,368.99, is for the supply of the cancer medication JEVTANA 60 MG/1.5 ML KIT 1.5ML. The contract is a firm fixed-price delivery order with a completion date of May 30, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JEVTANA 60 MG/1.5 ML KIT 1.5ML, a pharmaceutical product, with a ceiling value of $16,377.08 and a completion date of January 30, 2025. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,377.08, is for the supply of Jevtana 60 mg/1.5 ml kit, a specialty medication used in cancer treatment. The contract has a firm fixed price pricing type and an ultimate completion date of February 12, 2025. AmerisourceBergen is the prime contractor, and there is no indication of any...
- The Defense Logistics Agency Troop Support Medical awarded a $14,338.92 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 60 milligram/1.5 milliliter kits of JEVTANA, an injectable medication used to treat prostate cancer. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three week period concluding on August 28, 2023. The delivery order was issued under the Medical-Surgical Prime Vendor contract, a multiple...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $7,169.46 to supply JEVTANA 60 MG/1.5 ML KIT 1.5ML pharmaceutical products. Performance will take place at Amerisourcebergen's Conshohocken, Pennsylvania facility, with completion by December 29, 2023. The delivery order was awarded against an indefinite delivery contract held by Amerisourcebergen's Corporate Office division to provide pharmaceuticals and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,188.54 firm fixed-price delivery order is for the supply of JEVTANA 60 MG/1.5 ML KIT 1.5ML, a pharmaceutical product, with a period of performance through March 2025. The award is not associated with a set-aside program. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZD8Delivery Order
The Defense Logistics Agency awarded a $49,131.24 delivery order to AmerisourceBergen Drug Corp for the supply of JEVTANA (cabazitaxel) 60 mg/1.5 mL kits on July 22, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. JEVTANA is a chemotherapy agent used in oncology treatment, and this delivery order represents one of numerous pharmaceutical supply acquisitions that DLA Medical Supply Chain executes to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's performance under this IDC demonstrates its capability to meet federal pharmaceutical procurement requirements through open competition and positions the company as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.1k | 7/22/25 |